ADC Therapeutics SA (ADCT) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for ADC Therapeutics SA (US:ADCT), trading at 1.11. In 2025, ADC Therapeutics SA generated $81.36 Million in revenue and -$141.44 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for ADC Therapeutics SA is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 1.11
- Recent Revenue (2025): $81.36 Million
- Free Cash Flow (2025): -$141.44 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.